UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Annals of the rheumatic diseases, 2016-09, Vol.75 (9), p.1583-1594

2016

Volltextzugriff (PDF)

SP0095 EULAR/ERA-EDTA Recommendations for The Management of ANCA-Associated Vasculitis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.24-24

Mukhtyar, C.

2016

Volltextzugriff (PDF)

EULAR recommendations for the management of primary small and medium vessel vasculitis

Annals of the rheumatic diseases, 2009-03, Vol.68 (3), p.310-317

2009

Volltextzugriff (PDF)

EULAR recommendations for the management of large vessel vasculitis

Annals of the rheumatic diseases, 2009-03, Vol.68 (3), p.318-323

2009

Volltextzugriff (PDF)

Modification and validation of the Birmingham Vasculitis Activity Score (Version 3)

Annals of the rheumatic diseases, 2009-12, Vol.68 (12), p.1827-ard

2009

Volltextzugriff (PDF)

Early referral of patients with suspected polymyalgia rheumatica - A systematic review

Seminars in arthritis and rheumatism, 2023-12, Vol.63, p.152260-152260, Article 152260

2023

Volltextzugriff (PDF)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.1004-1010

2008

Volltextzugriff (PDF)

Giant cell arteritis

British dental journal, 2021-06, Vol.230 (11), p.687-687

2021

Volltextzugriff (PDF)

Response to: 'Renal biopsies should be performed whenever treatment strategies depend on renal involvement' by Chemouny et al

Annals of the rheumatic diseases, 2017-08, Vol.76 (8), p.e28

2017

Volltextzugriff (PDF)

Re: ‘ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies’ by Mikulska et al

Clinical microbiology and infection, 2019-04, Vol.25 (4), p.531-532

2019

Volltextzugriff (PDF)

Standardized grip strength as an outcome measure in early rheumatoid arthritis

Scandinavian journal of rheumatology, 2013-01, Vol.42 (4), p.289-293

2013

Volltextzugriff (PDF)

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

Rheumatology (Oxford, England), 2011-05, Vol.50 (5), p.899-905

2011

Volltextzugriff (PDF)

Current state of tumour necrosis factor α blockade in Wegener’s granulomatosis

Annals of the rheumatic diseases, 2005-11, Vol.64 (suppl 4), p.iv31-iv36

2005

Volltextzugriff (PDF)

SAT0153 Giant Cell Arteritis – Incidence and Mortality

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A633-A634

2013

Volltextzugriff (PDF)

FRI0518 Ultrasound Definitions for Vasculitis in Cranial and Large Vessel Giant Cell Arteritis: Results of A Delphi Survey of The Omeract Ultrasound Large Vessel Vasculitis Group

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.626-626

2016

Volltextzugriff (PDF)

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.74-74

2016

Volltextzugriff (PDF)

Long-term patient survival in ANCA-associated vasculitis

Annals of the rheumatic diseases, 2011-03, Vol.70 (3), p.488-494

2011

Volltextzugriff (PDF)

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis

Clinical and experimental rheumatology, 2007-11, Vol.25 (6 Suppl 47), p.120

2007

Volltextzugriff (PDF)

Refractory urticarial vasculitis responsive to anti-B-cell therapy

British journal of dermatology (1951), 2009-02, Vol.160 (2), p.470-472

2009

Volltextzugriff (PDF)

Primary obturator pyomyositis

Rheumatology (Oxford, England), 2005-03, Vol.44 (3), p.408-410

2005

Volltextzugriff (PDF)

Clinical and biological assessment in systemic necrotizing vasculitides

Clinical and experimental rheumatology, 2006-03, Vol.24 (2 Suppl 41), p.S92

2006

Volltextzugriff (PDF)

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials

Annals of the rheumatic diseases, 2011-08, Vol.70 (8), p.1415-1421

2011

Volltextzugriff (PDF)

The role of biologic therapies in the management of systemic vasculitis

Autoimmunity reviews, 2006-04, Vol.5 (4), p.273-278

2006

Volltextzugriff (PDF)

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Annals of the rheumatic diseases, 2024-01, Vol.83 (1), p.15

2024

Volltextzugriff (PDF)

Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the editor: Early referral of patients with suspected polymyal

Seminars in arthritis and rheumatism, 2023-12, Vol.63, p.152310-152310, Article 152310

2023

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(66)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(33)
Rheumatology
(32)
Vasculitis
(14)
Medicin Och Hälsovetenskap
(13)
Medical And Health Sciences
(12)
Biological And Medical Sciences
(11)
Clinical Medicine
(11)
Diseases Of The Osteoarticular System
(11)
Medical Sciences
(11)
Female
(10)
Klinisk Medicin
(10)
Male
(10)
Reumatologi Och Inflammation
(10)
Rheumatology And Autoimmunity
(10)
Adult
(8)
Glucocorticoids - Therapeutic Use
(8)
Middle Aged
(8)
Aged
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

SP0095 EULAR/ERA-EDTA Recommendations for The Management of ANCA-Associated Vasculitis

EULAR recommendations for the management of primary small and medium vessel vasculitis

EULAR recommendations for the management of large vessel vasculitis

Modification and validation of the Birmingham Vasculitis Activity Score (Version 3)

Early referral of patients with suspected polymyalgia rheumatica - A systematic review

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

Giant cell arteritis

Response to: 'Renal biopsies should be performed whenever treatment strategies depend on renal involvement' by Chemouny et al

Re: ‘ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies’ by Mikulska et al

Standardized grip strength as an outcome measure in early rheumatoid arthritis

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

Current state of tumour necrosis factor α blockade in Wegener’s granulomatosis

SAT0153 Giant Cell Arteritis – Incidence and Mortality

FRI0518 Ultrasound Definitions for Vasculitis in Cranial and Large Vessel Giant Cell Arteritis: Results of A Delphi Survey of The Omeract Ultrasound Large Vessel Vasculitis Group

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis

Long-term patient survival in ANCA-associated vasculitis

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis

Refractory urticarial vasculitis responsive to anti-B-cell therapy

Primary obturator pyomyositis

Clinical and biological assessment in systemic necrotizing vasculitides

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials

The role of biologic therapies in the management of systemic vasculitis

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the editor: Early referral of patients with suspected polymyal

Suchergebnisse filtern